RecruitingNot ApplicableNCT05445180

Investigating the Neural Correlates of Cognitive Function in Psychosis Patients and Non-Psychiatric Controls With Cannabis Use

Investigating the Neural Correlates of Cognitive Function Associated With Cannabis Abstinence in Psychosis Patients and Non-Psychiatric Controls With Cannabis Use


Sponsor

Douglas Mental Health University Institute

Enrollment

134 participants

Start Date

Apr 21, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

Cognitive impairment is well established in people with psychosis and is associated with cannabis use. The current study will investigate the neurobiological basis of cognitive change associated with 28-days of cannabis abstinence in people with psychosis and non-psychiatric controls with cannabis use. Participants will be randomized to a cannabis abstinent group or a non-abstinent control group and will undergo magnetic resonance imaging at baseline and following 28-days of abstinence. This study will help characterize the neuropathophysiological processes underlying cognitive dysfunction associated with cannabis use and its recovery which may guide the development of novel interventions for problematic cannabis use.


Eligibility

Min Age: 16 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study is using brain scans (MRI) to investigate how regular cannabis (marijuana) use affects thinking and brain function in people with psychosis compared to people without a psychiatric diagnosis. **You may be eligible if...** - You use cannabis heavily (at least weekly for six or more months) or have a cannabis use disorder - You have an IQ of 75 or above - You are an outpatient receiving stable doses of medication for at least 2 months and are clinically stable (psychosis patient arm) - OR you are a non-psychiatric adult who uses cannabis heavily (control arm) **You may NOT be eligible if...** - You use other substances besides cannabis, nicotine, or caffeine - You have MRI contraindications (e.g., metal implants) - You have current suicidal or homicidal thoughts - You have had a head injury requiring hospitalization - You are under 16 years old Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALContingency management

Contingency management will be used to encourage abstinence


Locations(1)

Douglas Mental Health University Institute

Montreal, Quebec, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05445180


Related Trials